NR4A3 has been recognized as a tumor suppressor in various tumors.26 Consistent with this, our study revealed that NR4A3 is significantly downregulated in bladder cancer (BLCA) based on GEPIA database analysis, and its lower expression correlates with advanced TNM staging and poor patient survival. This evidence concerns the gene NR4A3 and urinary bladder carcinoma.